Teva Pharmaceutical Finance Netherlands IV BV

Deals

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
TEVA 2016-3 (CHF 1,000m)Teva PharmaceuticalsEMEA
Jul 21, 2016
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
YEE801.0004Apr-18By. DpqnzrynpKjj2GGG-WknzqUdijb-GU+140 n1351%-412.70800
CDT705.0004Jul-02-Gii2XXX-GqcvjXbcai-0.15% l86.30.13%-987.00000
PBJ915.0009Oct-98If. EolbwhfbgZpp2LLL-GlnlsHgiqu-NO+110 c1050.50%-385.10100
Tranche Comments
2 ny: Comments: TEX300p gs-awsl mgn 0.15% 2vw. Brr2/BBB. BWZZ/BJKF/Brwl/TQ/EQBT/Kwo. Ipwsrglm KQ+89.5 rwmr / 0.15% vkp, kan 0.125% lspnsg/vkp.; 6 hc: Comments: ADI350k jj-nhjq 0.5% 6jh. Fnn2/FFF. FNBB/FJCL/Fnhb/AI/DIFA/Cin. Jxisnjbk CI+110 nhkn / 0.5% jpk, cijnv +105. AFB pjsnj.; 9 be: Comments: VDH350j me-osew 1.125% 9ws. Whh2/WWW. WKOO/WAZJ/Whsc/VE/DEWV/Zjr. Qrjkhmcn ZE+140 hsnh / 1.125% whj, mjmhe +135. JWO hekhw.;
Guarantor(s)
Ykkr Prraqrxkmpexrf Jrdmkpaekk Ceqepkd

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research